Companies/US/SRTA

Strata Critical Medical, Inc.

Income flow

Annual
SRTA 10-K Income StatementPeriod 2025-12-31Source 10-K
Logistics$177MClinical$20MRevenue$197M-21% Y/YGross profit$41M-30% Y/YCost of revenue$156M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$197M
  • Logistics$177M89.7%
  • Clinical$20M10.3%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0Shares outTotal shares currently outstanding (issued and not retired).88.5MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).58.1M

Valuation

Trailing PE 9.6 (2025-12-31)PE trend

Fiscal PE1

PeriodEPSClosePE
2025-12-310.54.819.6

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.